Intracellular ph changes induced by sclerosing agents in peritoneal fibroblasts;Alteraciones del pH intracelular en fibroblastos peritoneales inducida por factures implicados en la esclerosis peritoneal

Nefrologia

Volumn 24, Issue 2, 2004, Pages 158-166

  Soria, M ^a   Arrieta, J ^b   Ugarte, I ^b   Moina, I ^b   Guerra, M ^a   Escanero, J ^a  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

Author keywords

Cultured fibroblasts; Intracellular pH; Na H antiporter; Peritoneal dialysis; Physiopathology; Sclerosing peritonitis

Indexed keywords

ACETIC ACID; AMILORIDE; BICARBONATE; CADMIUM; CARBON DIOXIDE; GLUCOSE; HYDROGEN; INTERLEUKIN 1; LACTIC ACID; SCLEROSING AGENT; SODIUM; ACETIC ACID DERIVATIVE; ADENOSINE TRIPHOSPHATASE (CALCIUM); DIALYSIS FLUID; HYPERTONIC SOLUTION; LACTIC ACID DERIVATIVE; SODIUM PROTON EXCHANGE PROTEIN;

ACIDOSIS; ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIALYSIS; EXTRACELLULAR MATRIX; FIBROBLAST; ION EXCHANGE; MOLECULAR INTERACTION; MOLECULAR MECHANICS; NONHUMAN; PH MEASUREMENT; RAT; SCLEROSING PERITONITIS; STATISTICAL SIGNIFICANCE; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FIBROSIS; INTRACELLULAR FLUID; ION TRANSPORT; METABOLISM; PATHOLOGY; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; PH; SCLEROSIS; WISTAR RAT;

ACETATES; AMILORIDE; ANIMALS; CADMIUM; CALCIUM-TRANSPORTING ATPASES; CELLS, CULTURED; DIALYSIS SOLUTIONS; FIBROBLASTS; FIBROSIS; GLUCOSE; HYDROGEN-ION CONCENTRATION; HYPERTONIC SOLUTIONS; INTERLEUKIN-1; INTRACELLULAR FLUID; ION TRANSPORT; LACTATES; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; RATS; RATS, WISTAR; SCLEROSING SOLUTIONS; SCLEROSIS; SODIUM-HYDROGEN ANTIPORTER;

EID: 3142755438     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Brown P. Baddeley H. Read AE. Davies JD. McGarry J. Sclerosing peritonitis, an unusual reaction to a beta-adrenergic-blocking drug (practolol). Lancet 2 (7895): 1477-1481, 1974.
2. Gandhi VC, Humayun HM, Ing TS, Daugirdas JT, Jablokow VR, Iwatsuki S, Geis WP, Hano JE: Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 140 (9): 1201-1203, 1980.
3. Slingeneyer A, Canaud B, Mion C: Permanent loss of ultrafiltratrion capacity of the peritoneum in long-term peritoneal dialysis: an epidemiological study. Nephron 33 (2): 133-138, 1983.
4. Kittur DS, Korpe SW, Raytch RE, Smith GW: Surgical aspects of sclerosing encapsulating peritonitis. [Review] Arch Surg 125 (12): 1626-1628, 1990.
5. Drukker W: Sclerosing peritonitis. Dial Transplant 13: 768, 1985.
6. Slingeneyer A: Preliminary report on a cooperative international study on sclerosing encapsulating peritonitis. Contrib Nephrol 57: 239-247, 1987.
7. Dobbie JW: New concepts in molecular biology and ultrastructural pathology of the peritoneum: their significance for peritoneal dialysis. Am J Kidney Dis 15 (2): 97-109, 1990.
8. Dobbie JW: Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 12 (1): 14-27, 1992.
9. Krediet RT, Struijk DG, Boeschoten EW, Koomen GC, Stouthard JM, Hoek FJ, Arisz L: The time course of peritoneal transport kinetics in continuous ambulatory peritoneal dialysis patients who develop sclerosing peritonitis. Am J Kidney Dis 13 (4): 299-307, 1989.
10. Heale WF, Letch KA, Dawborn JK: Long term complications of peritonitis in peritoneal dialysis. En: Peritoneal Dialysis. Atkins RC, Thomson NM (eds). Churchill Livingstone, Edinburgh: 224-230, 1982.
11. Niaudet P, Berard E, Revillon Y, Lothon M, Broyer M: Sclerosing encapsulating peritonitis in children. Contrib Nephrol 57: 230-238, 1987.
12. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa K. Sclerosing encapsulating peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: a report of the Japanese Sclerosing Encapsulating Peritonitis Study Group. Am J Kidney Dis 28 (3): 420-427, 1996.
13. Beavis MJ, Williams JD, Hoppe J, Topley N: Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent. Kinney Int 51 (1): 205-215, 1997.
14. Slingeneyer A: Preliminary report on a cooperative international study on sclerosing encapsulating peritonitis. Contrib Nephrol 57: 239-247, 1987.
15. Shaldon S, Koch KM, Quellhorst E, Dinarello CA: Pathogenesis of sclerosing peritonitis in CAPD. Trans Am Soc Artif Intern Organs 30: 193-194, 1984.
16. Shaldon S, Dinarello CA, Wyler DJ: Induction of interleukin-1 during CAPD. Contrib Nephrol 57: 207-212, 1987.
17. Calo L, Fracasso A, Cantaro S, Cozzi E, De Silvestro G, Plebani M, Bazzato G, Borsatti A. Plasticizers induced mononuclear cells interleukin 1 production: implications with peritoneal sclerosis. Clin Nephrol 40 (1): 57, 1993.
18. Korten G, Bottcher M, Jonas L: Scanning electron microscopy study of the peritoneum as a dialysis membrane, a morphological study on the etiology of sclerosing peritonitis. Z Urol Nephrol 81 (7): 473-479, 1988.
19. Binswanger U, Banmatter F, Kreuhs G y cols.: Chemical peritonitis during CAPD. En: CAPD. Legrain M (ed). Excerpta Medica. Amsterdam: 238-244, 1980.
20. Mackow RC, Argy WP, Winchester JF, Rakowski TA, Fields PA, Rotellar C, Schreiner GE: Sclerosing encapsulating peritonitis in rats induced by long-term intraperitoneal administration of antiseptics. J Lab Clin Med 112 (3): 363-371, 1988.
21. Suga H, Teraoka S, Ota K, Komemushi S, Furutani S, Yamauchi S, Margolin S: Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats. Exp Toxicol Pathol 47 (4): 287-291, 1995.
22. Arrieta J, Soria MS, Palacio C: Cellular Mechanisms of Acetate-induced Peritoneal Fibrosis on CAPD. Nephr ol Dial Transp 8 (9): 1017, 1993.
23. Soria MS, Arrieta J, Guerra M, Molina J, Hernández I: Descenso del pH intracelular de fibroblastos peritoneales inducido por interleukina-1. Efectos combinados Na/Ca/H en la inducción de la mitosis. Nefrología 16 (6): 573, 1996.
24. + exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferation. Biochem Biophys Acta 988: 73-93, 1989.
25. Kristensen SR, Pedersen FB: Cytotoxicity testing of two CAPD dialysis fluids in a model system of quiescent fibroblasts. Nephrol Dial Transplant 8 (2): 163-167, 1993.
26. Batlle DC, Peces R, LaPointe MS, Ye M, Daugirdas JT. Cytosolic free calcium regulation in response to acute changes in intracelluiar pH in vascular smooth muscle. Am J Physiol 263: C932-C943, 1993.
27. Ashihara T, Aaserga R: Cell synchronization. En: Methods in Enzymology. Jacoby WB y Pastan IH, eds. Academic Press, San Diego. 58: 248-263, 1979.
28. Grynkiewicz G, Poenie M, Tsien RY: A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260 (6): 3440-3450, 1985.
29. Thomas JA, Buchsbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 18 (11): 2210-2218, 1979.
30. + antiporter of lymphocytes from the spontaneously hypertensive rat: role of intracellular pH. J Clin Invest 85: 1734-1739, 1990.
31. Roos A, Boron WF. Intracellular pH. Physiol Rev 61: 296-434, 1981.
32. Griendling KK, Berk BC, Gimbrone MA Jr, Alexander RW: Regulation of Angiotensin II-induced diacylglycerol formation by intracelluiar pH in cultured vascular smooth cells. Circulation 76 (Supl. 4): 224, 1987.
33. Stea A, Alexander SA, Nurse CA: Effects of pHi and pHe on membrane currents recorded with the perforated-patch method from cultured chemoreceptors of the rat carotid body. Brain Res 567: 83-90, 1991.
34. + exchange pathway: reversibility of transport and asymmetry of the modifier site. J Gen Physiol 84: 585-600, 1984.
35. + antiport of human neutrophils. Am J Physiol 250: 283-291, 1986.
36. Miyata Miyata Y, Asano Y, Muto S: Hyperosmotic mannitol activates basolateral NHE in proximal tubule from P-glycoprotein null mice. Am J Physiol Renal Physiol 282 (4): F718-729, 2002.
37. 2+ ATPase in vascular smooth muscle cells. J Clin Invest 95: 1480-1489, 1995.
38. Ganz MB, Boyarsky G, Sterzel RB, Boron WF: Arginine vasopressin enhances pHi regulation in the presence of HCO3-by stimulating three acid-base transport systems: Nature 337 (6208): 648-651, 1989.
39. Soria MS, Arrieta J, Guerra M, Olivar E, Rodrigo MT: Mecanismos de activación de la mitosis en fibroblastos peritoneales. Estudio de los factores implicados en la peritonitis esclerosante. Nefrología 16 (6): 573, 1996.